Oxford Study Clears Semaglutide of Neuro/Psychiatric Risks, Suggests Cognitive and Addiction Benefits
Researchers at the prestigious Oxford University in the UK have unveiled groundbreaking real-world data on...
Simcere Pharmaceutical’s COVID-19 Therapy Xiannuoxin Earns Full Approval in China
Simcere Pharmaceutical Group (HKG: 2096), a biopharmaceutical company based in China, has announced that its...
Beijing Tsingke Biotech Partners with Zhejiang University’s Innovation Center for Nucleic Acid Drug Delivery
Beijing Tsingke Biotech Co., Ltd., a prominent player in the DNA/RNA synthesis domain based in...
Jiangsu Hengrui’s Subsidiary Conducts First Surgical Dosing in Parkinson’s Gene Therapy Clinical Trial
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading pharmaceutical company in China, has announced...
Medtronic Launches Advanced Signia Stapler in China, Expanding Surgical Capabilities
Medtronic (NYSE: MDT), the US-Irish medical device giant, has announced the launch of its intelligent...
Shanghai Escugen Initiates Phase III Clinical Trial for Breast Cancer Drug Candidate ESG401
Shanghai Escugen, a biopharmaceutical company based in China, has announced the dosing of the first...
Ipsen Strikes Global Licensing Deal with Foreseen Biotechnology for First-in-Class ADC FS001
Ipsen (EPA: IPN; OTCMKTS: IPSEY), a French biopharmaceutical company, has announced a global licensing agreement...
Eisai and Biogen’s Alzheimer’s Therapy Leqembi Receives Marketing Approval in Hong Kong
Eisai Co., Ltd, a Japanese pharmaceutical company, along with its co-development partner Biogen Inc. (NASDAQ:...
Pfizer’s Once-Daily Danuglipron Selected for Full Clinical Development for Type 2 Diabetes and Obesity
Pfizer Inc. (NSE: PFIZER), a leading pharmaceutical company in the U.S., has announced that a...
Novo Nordisk’s Awiqli Faces FDA Setback as BLA Draws Complete Response Letter
Novo Nordisk A/S (NYSE: NVO) announced that the U.S. Food and Drug Administration issued a...
CSPC Pharmaceutical’s RSV mRNA Vaccine SYS6016 Receives Clinical Trial Approval from NMPA
CSPC Pharmaceutical Group Ltd (HKG: 1093), a leading pharmaceutical company based in China, has announced...
Sichuan Biokin Pharmaceutical Gets NMPA Approval for BL-M14D1 Clinical Trial in Solid Tumors
Sichuan Biokin Pharmaceutical Co., Ltd (SHA: 688506), a pharmaceutical company based in China, has announced...
Beijing Sun-Novo Gets NMPA Green Light for STC008 Clinical Trial in Tumor Cachexia
Beijing Sun-Novo Pharmaceutical Research Co., Ltd (SHA: 688621), a biopharmaceutical company based in China, has...
Haohai Biotech’s Sodium Hyaluronate Gel Receives NMPA Approval for Aesthetic Treatments
Shanghai Haohai Biological Technology Co. Ltd (HKG: 6826, SHA: 688366) has announced that it has...
Danaher Corporation Launches Western Innovation Center in Chongqing
Danaher Corporation (NYSE: DHR), a leading science and technology services provider based in the U.S.,...
Salus Biotech Partners with Xi’an Jiaotong University for Single-Cell Omics Innovation
Salus Biotech, a Shenzhen-based biotechnology company, has entered into a strategic partnership with the Single-cell...
KeChow Pharma’s Keluping, First NRAS Mutant Melanoma Therapy, Hits the Market
Shanghai-based KeChow Pharma has announced the official market launch of its groundbreaking drug, Keluping (tunlametinib),...
Biokin Pharmaceutical Co., Ltd Eyes Secondary Listing on HKEX, Co-Sponsored by Goldman Sachs and Others
Sichuan Biokin Pharmaceutical Co., Ltd (SHA: 688506), a company listed on the Shanghai Stock Exchange’s...
Allist Pharmaceuticals Faces Arbitration Over Promotion Agreement for Furmonertinib
Allist Pharmaceuticals Co., Ltd, a Shanghai-based biopharmaceutical company, has announced that it has received a...
Bayer Restructures China Business into Five Sectors and Six Departments
Bayer (ETR: BAYN), the German pharmaceutical and life sciences giant, has announced a strategic restructuring...